AZTR vs UTHR · $3.7M cap vs P/E 20, rev $1.56B
Azitra Inc (AZTR) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Azitra Inc (AZTR) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AZTR revenue for 2025-12-31 was $0. Net income was -$11.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AZTR currently screens at market cap $3.7M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
AZTR currently screens at market cap $3.7M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the AZTR and UTHR stock pages for the full models.
Not investment advice.